Journal of Parenteral and Enteral Nutrition · 2020 · 14 citations · 29 references
MedicineChild HealthPediatricsChild NutritionPediatric NutritionSarcopeniaAdipose TissueBody CompositionMuscle DevelopmentMuscle Mass AssessmentPediatric HepatologyPediatric Liver DiseaseAbdominal AdiposityAbdominal Wall AssessmentDeceased Donor Liver TransplantationMagnetic Resonance Imaging Muscle AssessmentMuscle Function MeasurementPediatric Abdominal ImagingPhysical Performance ImpairmentSarcopenia In Liver Disease
BACKGROUND: Sarcopenia is defined as reduced skeletal muscle mass (SMM) or myopenia and altered muscle function and physical performance. It is unknown whether myopenia in children with end-stage liver disease (ESLD) adversely impacts clinical outcomes. We hypothesized that myopenia was prevalent in children with ESLD and related to suboptimal nutrition intake contributing to gross motor and growth delay, increased hospitalization, and medical complications. METHODS: ) and adipose tissue (total, visceral, subcutaneous adipose tissue [SAT], ) determinations at the third and fourth lumbar vertebrates during liver transplantation (LTx) assessment. ESLD children (n = 30) were age- and gender-matched to healthy controls (n = 24). Myopenia was defined as SMM index z score <-2 and low SAT was defined as SAT index z-score <-1.5. Anthropometric, biochemical, and clinical data (hospitalization, complications, growth, neurodevelopment, energy/protein intake) were collected at LTx assessment, LTx, and post LTx (first hospitalization, 6 months, 12 months). RESULTS: Four distinct body composition phenotypes in children with ESLD were found: (1) myopenia with low SAT (17%;5 of 30), (2) myopenia (3%;1 of 30), (3) low SAT (20%;6 of 30), (4) normal muscle mass and SAT (60%;18 of 30). Myopenia with low SAT was prevalent in older (>2 years), male children and was associated with gross motor delay, reduced energy intake, and increased hospitalization and infections (total/viral/fungal). CONCLUSIONS: Myopenia, accompanied by low SAT in children with ESLD, is associated with adverse clinical outcomes. Rehabilitation strategies aimed at combating myopenia in children are important.
29
Sarcopenia: revised European consensus on definition and diagnosis
Alfonso J. Cruz‐Jentoft, Gülistan Bahat, Jürgen M. Bauer et al. · Age and Ageing · 2018 · 14K citations · Full text
Sex differences in human adipose tissues – the biology of pear shape
Kalypso Karastergiou, Steven R. Smith, Andrew S. Greenberg et al. · Biology of Sex Differences · 2012 · 1.1K citations · Full text
Werner Blum, P. Englaro, S. Hanitsch et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 653 citations · Full text
Medicine, Endocrinology, Pediatrics +16
A multicenter study to define sarcopenia in patients with end‐stage liver disease
Elizabeth J. Carey, Jennifer C. Lai, Connie W. Wang et al. · Liver Transplantation · 2017 · 477 citations · Full text